this phase i study was conducted to determine the maximal safe concentration of 4-hydroperoxycyclophosphamide ( 4hc ) that could be used for in vitro treatment of bone marrow from patients with acute leukemia undergoing autologous bone marrow transplantation .
C0005953
bone marrow
C0085669
acute leukemia